Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call
Vivos Therapeutics plans to release its full year 2025 financial results after market close on April 15, 2026, followed by a conference call discussing operational updates including strategic collaborations impacting near-term revenue growth and cash burn. The company focuses on innovative nonsurgical treatments for obstructive sleep apnea (OSA) an…